Completing treatment for muscle-invasive bladder cancer (MIBC) is a major milestone, but it often comes with new concerns about what happens next. You may wonder how you’ll be monitored, what signs to watch for, and what treatment options may be available if the cancer returns. Keep reading for insights from Fox Chase Cancer Center’s Dr. Elizabeth Plimack.
Monitoring after treatment: What to expect
Once treatment for MIBC is complete, patients typically begin a structured follow-up plan with their care team. These appointments may include imaging scans, lab work, urine testing, and other evaluations, depending on the treatment received.
Dr. Plimack explains, “In MIBC, once treatment is complete, we do [follow-ups] every 3 months for 2 years, and then it can stretch out to 5 years.”
While this is a general guideline, she notes that “many exceptions” exist and that monitoring recommendations are tailored to each individual patient’s situation. The exact schedule depends on factors like treatment response, risk of recurrence, and overall health.
Having regular follow-up appointments can be reassuring, especially during the first few years after treatment when the risk of recurrence is often highest.
Evidence-based guidance powered by NCCN Guidelines®
Personalized treatment plans shaped by the latest oncology standards—tailored to your diagnosis.
Get started
View your personalized treatment plan in the Outcomes4Me app
Use your diagnosis to unlock personalized NCCN Guidelines®-aligned recommendations.
Continue in app
If recurrence happens, clinical trials offer new options
Treatment decisions are highly individualized if bladder cancer returns. Dr. Plimack shares that researchers are “actively looking and investigating treatment in all of those spaces,” meaning that clinical teams are working to improve therapies for recurrence at every stage. While it may still be too early to identify which emerging therapies are most promising, she emphasizes that specialists are “always looking for them” and striving to make better treatment options available.
This means that even if the cancer returns, there may be multiple paths forward, including standard therapies and clinical trial opportunities.
Dr. Plimack explains that clinical trials are often introduced “at a time when the last treatment stopped working,” or when it is time to consider a different approach.
It can be especially helpful to consult a bladder cancer specialist when treatment changes are recommended. Dr. Plimack suggests that if your doctor proposes a new treatment, that can be a good time to ask a specialist. Seeking a second opinion may help uncover additional treatment opportunities and connect patients to experts who focus specifically on bladder cancer.
Coping with the fear of recurrence
For many survivors, one of the most difficult parts of life after treatment is managing the fear that the cancer may come back. It is common to feel anxious before scans or to worry that every new symptom could be a sign of recurrence.
Dr. Plimack acknowledges that this emotional burden is very real, saying that “there’s some amount of anxiety that just comes with this.” One approach she finds helpful is encouraging patients to think through what they fear most, because “visualizing what you’re afraid of helps it feel less scary.” For some people, having a clearer understanding of what would happen in a worst-case scenario can make uncertainty feel more manageable.
She also encourages patients to build trust in the monitoring process. After a few clean scans, she believes “it’s okay to expect your scan to be good,” while also remembering that your care team will be there to guide you if something changes.
Still, fear of recurrence can be overwhelming, and emotional support is an important part of survivorship. Dr. Plimack recommends seeking help from a therapist with cancer-specific experience if anxiety becomes difficult to manage. Mental health support, patient advocacy groups, and survivorship programs can all help patients feel less alone during this stage of care.
Symptoms you shouldn’t ignore
Even after treatment ends, it is important to stay alert to new or worsening symptoms. Some symptoms may require urgent medical attention, while others should prompt a call to your care team.
Dr. Plimack stresses that serious symptoms like chest pain or difficulty breathing should never be ignored and warrant immediate emergency care. She also notes that if a patient is unable to urinate, it should be treated as an urgent issue because it “can be dangerous if it persists.”
Patients receiving immunotherapy should be especially aware of new side effects. Symptoms like persistent diarrhea, sudden fatigue, or anything that feels significantly different from normal should be reported right away. As Dr. Plimack advises, “if something doesn’t feel right, don’t blow it off.” Even symptoms that seem minor may be important to your treatment team. She empahsizes, “Interface with your care team, that’s what they’re there for.”
If you would like to connect with an Outcomes4Me oncology nurse practitioner at no charge through the Outcomes4Me app, using the “Ask Outcomes4Me” button.
Personalized support for real care decisions
Understand your diagnosis, explore clinical trials, and track symptoms--all in one place.
Get started
Compare treatments, prepare for appointments, and track side effects—all in the app
Built for your diagnosis, Outcomes4Me gives you the tools to make confident, informed decisions—right when you need them.
Continue in app
